跳至主要内容
临床试验/JPRN-UMIN000052645
JPRN-UMIN000052645尚未招募Unknown

Derma AI: A NON-INTERVENTIONAL, PROSPECTIVE, MULTICENTER STUDY IN JAPAN FOR DEVELOPMENT AND UTILITY INVESTIGATION OF EDUCATIONAL ARTIFICAL INTELLIGENCE (AI) SOFTWARE TO SUPPORT ASSESSMENT OF ATOPIC DERMATITIS SEVERITY - Derma AI

Pfizer Japan Inc.0 个研究点目标入组 1,000 人开始时间: 2023年10月30日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Participants are excluded from the study if any of the following criteria apply: 1. Patients concomitant with skin diseases which affect the area where AD skin image is photographed. 2. Patients whose symptoms are clearly in remission in the area affected by AD and whose EASI score is clearly zero. 3. Investigator site staff directly involved in the conduct of the study and their family members, site staff otherwise supervised by the investigator, and sponsor and sponsor delegate employees directly involved in the conduct of the study and their family members.

研究者

相似试验

Derma AI: A NON-INTERVENTIONAL, PROSPECTIVE,... | 临床试验